Curious about our science? Our CMO, Jay Barth, delivers a concise overview about our work to #RewriteRNA and the latest from our lead program in ABCA4 retinopathies all in one take!

Listen to what Jay has to say from the frontlines of #ARVO23 here 👇
https://www.ophthalmologytimes.com/view/arvo-live-ascidian-therapeutics-research-into-gene-therapy

Curious about our science? Our CMO, Jay Barth, delivers a concise overview about our work to #RewriteRNA and the latest from our lead program in ABCA4 retinopathies all in one take!

Listen to what Jay has to say from the frontlines of #ARVO23 here 👇
https://www.linkedin.com/posts/ascidian-therapeutics_arvo-live-ascidian-therapeutics-research-activity-7057034778151149568-tG5y?utm_source=share&utm_medium=member_desktop